Toxsta 200 Units
Original price was: 72,00 €.66,00 €Current price is: 66,00 €.
Buy Toxsta 200 Units online through Botoderm to equip your high-volume aesthetic practice with a premium, cost-effective South Korean neuromodulator. Manufactured by the globally recognized biopharmaceutical company JETEMA Co., Ltd., this 200-unit high-capacity Botulinum Toxin Type A is developed from a highly stable European National Institute strain. Utilizing a patented vacuum-drying process, Toxsta 200U features an exceptionally low protein content that minimizes patient immune resistance while maximizing clinical ROI for heavy-dose procedures like masseter reduction and hyperhidrosis management. Every bulk order is shipped securely via our mandatory medical cold-chain logistics protocol.
- Potency: 200 Units (IU) high-capacity vacuum-dried sterile vial
- Manufacturer: JETEMA Co., Ltd. (South Korea)
- Clinical Advantage: Patented vacuum-drying process resulting in low immunogenicity while optimizing ROI for large doses
- Logistics: Validated temperature-controlled cold-chain delivery
Maximize Clinic ROI and Patient Safety with Toxsta 200 Units
Buy Toxsta 200 Units online to optimize your clinic’s profitability and provide patients with a highly predictable, low-resistance neuromodulator. Sourced directly from South Korea’s KOSDAQ-listed pharmaceutical innovator, JETEMA Co., Ltd., this 200-unit high-capacity Botulinum Toxin Type A is meticulously engineered for heavy-dose clinical applications. Practitioners running high-turnover medical spas select Toxsta for its strict cGMP compliance, its original European strain, and its ability to drastically lower the per-unit cost on complex aesthetic procedures.
High-Capacity ROI Meets Patented Vacuum-Drying Technology
Unlike standard toxins that rely on traditional freeze-drying, Toxsta is processed using JETEMA’s highly advanced, patented vacuum-drying technology. Combined with a highly stable Clostridium botulinum strain sourced from the European National Institute, this specialized drying method drastically reduces the product’s overall accessory protein load. For high-volume clinics, this low-protein profile is critical. It drastically reduces the risk of immunogenicity, ensuring that patients returning for high-dose maintenance treatments over several years are highly unlikely to develop neutralizing antibodies, thereby securing your long-term patient retention.
Advanced Clinical Indications for 200-Unit Vials
While the standard 100U vial is suitable for baseline facial mapping, the expanded Toxsta 200 Units capacity is strategically sized for macro-muscle applications and advanced therapeutic aesthetic protocols:
- Masseter Contouring (Jawline Slimming): Delivering heavy, symmetrical relaxation to oversized masseter muscles for lower facial contouring and bruxism (teeth grinding) management.
- Primary Axillary Hyperhidrosis: Administering high-volume, localized intradermal blocks to overactive sweat glands in the underarms, palms, or soles.
- Comprehensive Multi-Patient Tracking: Smoothing severe dynamic wrinkles across the glabella, forehead, and lateral canthal lines across multiple patients efficiently without constantly opening new vials.
Efficacy Timeline: Reliable Onset and Longevity
Toxsta is highly regarded by medical professionals for its predictable tissue integration and exceptionally stable batch-to-batch toxicity:
- Initial Onset: Visual relaxation of the targeted facial and body muscles generally begins to present within 3 to 7 days post-treatment.
- Peak Result: Complete neuromodulatory integration and maximum cosmetic smoothing achieve total stability at approximately 14 days.
- Duration: Thanks to its advanced stabilization, the therapeutic aesthetic benefits remain dynamically active for an average of 3 to 6 months, naturally tapering based on individual patient metabolism and the administered dosage.
Technical Specifications
| Parameter | Clinical Specification |
|---|---|
| Product Name | Toxsta 200unit |
| Active Substrate | Clostridium botulinum toxin type A |
| Format | Vacuum-dried white powder for injection |
| Dosing Capacity | 200 Units (IU) per vial |
| Storage Needs | Refrigerated condition (2°C to 8°C). Do not freeze. |
Reconstitution Protocol & Dilution Chart for Toxsta 200U
Reconstitution must be executed under strict sterile clinical conditions by qualified healthcare professionals using preservative-free 0.9% Sodium Chloride (Normal Saline).
Because this is a high-capacity 200-unit vial, the required saline volume is double that of a standard 100-unit vial to achieve an identical unit-per-mL concentration. Because Toxsta utilizes JETEMA’s patented vacuum-drying process, the 200 Units of toxin are deposited as an ultra-thin, nearly invisible film on the bottom of the glass. The vial may appear nearly empty prior to reconstitution; this is a normal product characteristic. Gently introduce the normal saline along the inner glass wall. Slowly swirl the vial in a circular motion until the product completely dissolves into a clear liquid solution.
- Standard 10U / 0.1mL Dosing: Slowly infuse 2.0 mL of sterile saline.
- Standard 5U / 0.1mL Dosing: Slowly infuse 4.0 mL of sterile saline.
- Standard 4U / 0.1mL Dosing: Slowly infuse 5.0 mL of sterile saline.
- Light 2.5U / 0.1mL Dosing: Slowly infuse 8.0 mL of sterile saline.
Frequently Asked Questions (FAQ)
Why should my practice transition to the Toxsta 200 Units configuration?
Purchasing the 200-Unit configuration provides a significantly lower cost-per-unit, optimizing profit margins for high-volume practices. It dramatically reduces packaging waste, saves critical preparation time, and is the absolute baseline standard for heavy-dose procedures like masseter reductions, neck banding relief, or body contouring.
Why does the Toxsta 200U vial look almost empty when unboxed?
Toxsta is manufactured using a highly advanced vacuum-drying process rather than standard freeze-drying. This deposits the 200 Units of active neurotoxin as an ultra-thin, nearly invisible film on the bottom of the glass. Rest assured, the full 200U high-capacity potency is present and activates instantly upon saline reconstitution.
How should opened and unopened Toxsta 200U vials be stored?
Unopened vacuum-dried vials must be transferred immediately to a secure medical refrigerator operating continuously between 2°C and 8°C. Do not expose the dry product to heat or freezing temperatures. Once reconstituted, the high-capacity solution should be used during your current clinic session, or kept refrigerated (2°C to 8°C) and safely utilized within 24 hours.
Professional Medical Procurement Disclaimer: Toxsta 200 Units is a prescription-only, high-potency professional medication restricted exclusively to licensed healthcare professionals, dermatologists, and certified injectors. Botoderm assumes absolutely no clinical or legal liability for adverse reactions, complications, or loss of product efficacy due to unauthorized self-administration, home use, or poor storage handling post-delivery.
Only logged in customers who have purchased this product may leave a review.
Authentic Toxsta by JETEMA Co., Ltd.
Buy Toxsta online to supply your advanced aesthetic practice with a next-generation neuromodulator explicitly engineered for purity and safety. Manufactured by South Korea's highly respected biopharmaceutical innovator, JETEMA Co., Ltd., Toxsta is a premium Botulinum Toxin Type A cultivated from an original, highly stable European National Institute strain. Utilizing patented vacuum-drying technology, Toxsta drastically reduces unnecessary complexing proteins to deliver highly predictable, natural-looking wrinkle relaxation while actively preventing clinical immunogenicity. Explore our authentic Toxsta wholesale inventory, available in both versatile 100U and high-capacity 200U configurations, fully secured by Botoderm's mandatory medical cold-chain logistics.
The Clinical Superiority of a Low-Resistance Formulation
As the aesthetic injectable market matures, a growing challenge for high-volume clinics is clinical toxin resistance—a phenomenon where patients develop neutralizing antibodies after years of consecutive neurotoxin treatments, causing the product to lose its efficacy. Toxsta directly solves this clinical hurdle. Through its advanced purification process, JETEMA significantly lowers the accessory protein load within the vial. This drastically minimizes the introduction of foreign bacterial residues to the patient's immune system, ensuring Toxsta remains highly effective even for clients undergoing long-term aesthetic maintenance programs.
Patented Vacuum-Drying Technology
Most traditional neurotoxins use a standard lyophilization (freeze-drying) process, leaving a large, visible white powder cake in the vial. Toxsta employs JETEMA's patented vacuum-drying technique. This cutting-edge method deposits the active botulinum toxin as an ultra-thin, nearly transparent film at the bottom of the glass. While the vial may appear "empty" upon arrival, this vacuum-drying process actually preserves the delicate structural integrity of the neurotoxin far better than traditional freezing, leading to exceptionally stable batch-to-batch toxicity and a rapid, seamless reconstitution process when introduced to sterile saline.
Optimized Inventory: 100U and 200U Configurations
To support your clinic's precise treatment protocols and heavy scheduling demands, Botoderm supplies both critical Toxsta configurations:
- Toxsta 100 Units: The foundational, highly versatile baseline volume ideal for precise facial mapping, delicate micro-toxin therapies, and standard corrections of the glabella, forehead, and crow's feet.
- Toxsta 200 Units: High-capacity vials meticulously designed to maximize cost-efficiency and clinical ROI for large-scale anatomical sculpting, masseter reduction (jawline slimming), and heavy-dose primary hyperhidrosis management.
Unbroken Temperature-Controlled Logistics
Despite its advanced stabilization, Toxsta contains delicate biological proteins. Any exposure to uncontrolled heat spikes during transit can permanently denature the active chains, rendering the product clinically ineffective. At Botoderm, we protect your commercial investment by enforcing a strictly validated medical cold-chain shipping protocol. Every wholesale order is packed in heavy-duty insulated containers with medical-grade gel ice packs, ensuring that the mandatory 2°C to 8°C environment remains completely unbroken from our distribution center to your clinic doors.
Frequently Asked Questions About Toxsta Wholesale
Is Toxsta manufactured by a reputable company?
Yes. Toxsta is developed and manufactured by JETEMA Co., Ltd., a highly respected, KOSDAQ-listed biopharmaceutical company in South Korea known for its strict adherence to cGMP standards and its use of an original European National Institute botulinum strain.
Why does the Toxsta vial appear empty upon delivery?
Because Toxsta utilizes a highly advanced, patented vacuum-drying process rather than standard freeze-drying, the neurotoxin is deposited as an ultra-thin, nearly invisible film on the bottom of the glass. The full 100U or 200U potency is completely intact and will activate instantly upon sterile saline reconstitution.
What are the storage guidelines for Toxsta vials?
Unopened vacuum-dried vials must be stored immediately in a secure medical refrigerator operating continuously between 2°C and 8°C. Do not freeze the product. Following sterile reconstitution with preservative-free 0.9% normal saline, the clear solution should be injected immediately or kept refrigerated (2°C to 8°C) and safely used within 24 hours.
Are wholesale purchases of Toxsta restricted?
Yes. Toxsta is a high-potency, prescription-strength injection drug. To ensure absolute patient safety and meet strict international medical distribution guidelines, wholesale access on Botoderm is legally restricted to licensed healthcare professionals, certified dermatologists, plastic surgeons, and verified medical spa buyers.
Professional Medical Procurement Disclaimer: The manufacturing details, technical specifications, and clinical guidelines featured on this brand page are intended purely for commercial B2B procurement and medical supply planning. Botoderm assumes absolutely no clinical or legal liability for adverse reactions, complications, or loss of product efficacy due to unauthorized use, improper reconstitution, or third-party negligence post-delivery.
Details
Toxsta is a high-quality botulinum toxin treatment formulated for the temporary improvement of dynamic facial lines, especially glabella lines caused by repeated muscle movement.
Its active ingredient, Botulinum Toxin Type A, works by relaxing the muscles that create these wrinkles, giving the skin a smoother and more refreshed look.
Made with European strain and produced under strict GMP standards, it delivers fast, consistent wrinkle-softening results.
What makes this product stand out is its extremely high purity level of over 99%, which supports faster action and more consistent results. This level of purity helps reduce the formation of antibodies, allowing the treatment to remain effective over time.
Toxsta is made without animal or typical plant-based allergens, and the chances of irritation is less.
Key Benefits of Toxsta (Toxta)
- Smooths facial wrinkles by gently relaxing targeted muscles
- Provides fast, consistent results due to high toxin purity
- Supports natural-looking rejuvenation with minimal discomfort
- Offers a safer treatment with allergen-free formulation
- Reduces antibody formation risk for long-term effectiveness
Who Is This Product For?
- Individuals desiring an effective, safe glabella lines treatment.
- Individuals seeking a high-purity toxin with low immunogenicity.
- Anyone looking for smoother, younger-looking skin.
Important Notice Before Ordering Toxins
All botulinum toxin products are shipped in insulated packaging with ice packs to maintain temperature during transit. However, due to international shipping, ice packs may melt and toxins may arrive warm or hot, especially during summer.
As shipping conditions are beyond our control, we are unable to offer refunds or reshipments for melted ice packs, warm product arrivals, or delays caused by shipping or customs.
Please review this information before completing your purchase.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.